Clinical-stage stem cell and regenerative medicine firm Cynata has four trials underway, three ending between late this year ...

Fortescue (ASX:FMG) surged by nearly 5% as iron ore prices continued to rise on the China news, hitting US$100.30 per tonne.

The rise and fall of Novo Resources is a cautionary tale about over-promotion, but its Pilbara gold prospects could yet yield ...

A little Chinese stimulus goes a long way for local Resources, sparking a 9.5pc surge to keep the market moving forward for ...

US rate cuts spark new gold highs up to US$2670/oz and De Grey hits nine-month high after baulking at Agnico takeover offer.

Social media has torn apart Coles and Woolworths' ESG reputations this week, with the duopoly accused of misleading pricing ...

Australian-Singaporean regenerative medicine company Osteopore (ASX:OSX) announced today it is undertaking a $20 million ...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes ...

Good morning, and Happy Friday! Here’s everything you need to know, and some things you don't, before the ASX opens today.

It may be made of paper, but China's biggest stimulus reports in months have sent ASX mining stocks to the moon.

Investors seized on August sell-off and US recession fears to buy up chip maker Nvidia, according to trading platform ...

Regis' Jim Beyer says the company remains in the dark on why a tailings dam at the McPhillamys gold project was rejected by ...